Treatment of glaucoma using phosphodiesterase inhibitors

Details Treatment of glaucoma using phosphodiesterase inhibitors Treatment of glaucoma using phosphodiesterase inhibitors

1988-05-31

1990-12-04

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 31535

Patent

active

049754289

ABSTRACT:
Lowering of intraocular pressure, e.g. in the treatment of glaucoma is carried out by administering a phosphodiesterase inhibitor to a patient. Particular ophthalmic pharmaceutical compositions are disclosed for topical application to the eye.

REFERENCES:
patent: 3978213 (1976-08-01), Lapinet et al.
patent: 4490374 (1984-12-01), Bandurco et al.
patent: 4721784 (1988-01-01), Combs
patent: 4753945 (1988-06-01), Gilbard et al.
Association for Research in Vision and Ophthalmology Annual Meeting Abstract, vol. 29, 1988 (mailed 3/18/88).
Arch. Int. Physiol. Biochem., Nov. 1984, 92(4): S69-79.
W. S. Hillis and M. Been European Heart Journal (1982)3, Supplement D), 97-101.

Affiliated with

Also associated with

Rating

Treatment of glaucoma using phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of glaucoma using phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glaucoma using phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-883507